Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-28T00:20:39.279Z Has data issue: false hasContentIssue false

Le SARM, en pleine forme et florissant au Canada. Que peut bien faire un médecin d'urgence?

Published online by Cambridge University Press:  21 May 2015

Heather Murray*
Affiliation:
Professeure agrégée, Départements de médecine et de santé communautaire et d'épidémiologie, Université Queen's, Kingston (Ontario)
*
Département de médecine d’urgence, Université Queen’s, 76, rue Stuart, Kingston ON K7L 2V7; télécopieur : 613 548–1374; [email protected]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorials • Éditoriaux
Copyright
Copyright © Canadian Association of Emergency Physicians 2009

References

RÉFÉRENCES

1.Stenstrom, R, Grafstein, E, Romney, M, et coll. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a Canadian emergency department. JCMU 2009;11:430–8.Google Scholar
2.Adam, HJ, Allen, VG, Currie, A, et coll. Community-associated methicillin-resistant Staphylococcus aureus: prevalence in skin and soft tissue infections at emergency departments in the Greater Toronto Area and associated risk factors. JCMU 2009;11:439–46.Google Scholar
3.Moran, GJ, Krishnadasan, A, Gorwitz, RJ, et coll. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355:666–74.Google Scholar
4.Boucher, HW, Corey, GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008;46(Suppl 5):S344–9.Google Scholar
5.Seybold, U, Kourbatova, EV, Johnson, JG, et coll. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006;42:647–56.Google Scholar
6.Gillet, Y, Issartel, B, Vanhems, P, et coll. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002;359:753–9.Google Scholar
7.Hageman, JC, Uyeki, TM, Francis, JS, et coll. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003–04 influenza season. Emerg Infect Dis 2006;12:894–9.Google Scholar
8.Fridkin, SK, Hageman, JC, Morrison, M, et coll. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436–44.Google Scholar
9.Lee, MC, Rios, AM, Aten, MF, et coll. Management and outcome of children with skin and soft tissue abscesses cause by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 2004;23:123–7.Google Scholar
10.Rajendran, PM, Young, D, Mauer, T, et coll. Randomized, double-blind, placebo controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2007;51:4044–8.Google Scholar
11.Hammond, SP, Baden, LR. Management of skin and soft-tissue infection — polling results. N Engl J Med 2008;359:e20.Google Scholar
12.Patrick, DM, Hutchinson, J. Antibiotic use and population ecology: How you can reduce your “resistance footprint.” JAMC 2009;180:416–21.Google Scholar